At a glance
ClinicalIndex Comparison RecordN/ACompleted· 32 enrolled
Drug / intervention
Desaturationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Validation of Next Generation INVOS NIRS Cerebral and Tissue Oximeter to Measure Cerebral and Somatic Tissue Oxygen Saturation in Healthy Volunteers
In Brief
A clinical study evaluating Desaturation for Oxygen Deficiency. Completed, enrolled 32 participants across 1 site.
Detailed Summary
This is a validation study of a near-infrared spectroscopy (NIRS) device designed to measure the cerebral tissue oxygen saturation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOxygen Deficiency
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedApr 2017
Enrollment StartMay 2017
Primary CompletionJul 2017
TodayJul 2026
First PostedApr 25, 2017
Enrollment StartMay 22, 2017
Primary CompletionJul 19, 2017
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 9.2 years ago
Interventions
Desaturationdevice
The delivered gas mixture will be adjusted to decrease the displayed saturation of peripheral oxygen. Each desaturation steps are of approximately 5 minutes duration with reduction in pulse oximeter oxygen saturation from 100 to 70%.